These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 2574743

  • 1. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
    Hedge SS, Ricci A, Amenta F, Lokhandwala MF.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
    [Abstract] [Full Text] [Related]

  • 2. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ, Apparsundaram S, Lokhandwala MF.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [Abstract] [Full Text] [Related]

  • 3. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL, Hilditch A, Robertson MJ, Drew GM.
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [Abstract] [Full Text] [Related]

  • 4. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats.
    Chen CJ, Lokhandwala MF.
    Clin Exp Hypertens A; 1992 Dec; 14(4):615-28. PubMed ID: 1352742
    [Abstract] [Full Text] [Related]

  • 5. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC, Lawson K, Thiry C, Cavero I.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [Abstract] [Full Text] [Related]

  • 6. Renal dopamine and tubular DA-1 receptors in the regulation of sodium excretion.
    Lokhandwala MF, Vyas SJ, Hegde SS.
    J Auton Pharmacol; 1990 Mar; 10 Suppl 1():s31-9. PubMed ID: 1983007
    [Abstract] [Full Text] [Related]

  • 7. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A, Healy DP.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):193-8. PubMed ID: 1677038
    [Abstract] [Full Text] [Related]

  • 8. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A, Moreau R, Bacq Y, Gaudin C, Braillon A, Lebrec D.
    Hepatology; 1991 Jan 01; 13(1):111-6. PubMed ID: 1671029
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
    Christie MI, Smith GW.
    J Pharmacol Exp Ther; 1994 Feb 01; 268(2):565-70. PubMed ID: 7906731
    [Abstract] [Full Text] [Related]

  • 10. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW, Comans EF, de Vries PM, Oe PL, Roos JC, Smit AJ, Streurman O, Donker AJ.
    Neth J Med; 1990 Jun 01; 36(5-6):267-78. PubMed ID: 1975651
    [Abstract] [Full Text] [Related]

  • 11. Renal dopamine and sodium excretion.
    Hegde SS, Lokhandwala MF.
    Am J Hypertens; 1990 Jun 01; 3(6 Pt 2):78S-81S. PubMed ID: 1974446
    [Abstract] [Full Text] [Related]

  • 12. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV.
    Dan Med Bull; 1998 Jun 01; 45(3):282-97. PubMed ID: 9675540
    [Abstract] [Full Text] [Related]

  • 13. Selective dopamine-1 receptor stimulation produces natriuresis by a direct tubular action.
    Hughes JM, Beck TR, Rose CE, Carey RM.
    J Hypertens Suppl; 1986 Dec 01; 4(6):S106-8. PubMed ID: 2886568
    [Abstract] [Full Text] [Related]

  • 14. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat?
    Clark KL, Robertson MJ, Drew GM.
    J Cardiovasc Pharmacol; 1991 Feb 01; 17(2):267-76. PubMed ID: 1709232
    [Abstract] [Full Text] [Related]

  • 15. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
    Nichols AJ, Koster PF, Brooks DP, Ruffolo RR.
    J Pharmacol Exp Ther; 1992 Jan 01; 260(1):269-74. PubMed ID: 1346161
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
    Zhao RR, Wang PH, Zhang WF, Fennell WH.
    Methods Find Exp Clin Pharmacol; 1992 Jan 01; 14(1):5-11. PubMed ID: 1352371
    [Abstract] [Full Text] [Related]

  • 17. Human vasodilator responses to a dopamine agonist: possible mechanisms.
    Redman D, Thom SA, Hughes AD, Hasan S, Sever PS.
    J Hypertens Suppl; 1985 Dec 01; 3(3):S177-8. PubMed ID: 2908815
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.
    Chen C, Lokhandwala MF.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar 01; 347(3):289-95. PubMed ID: 8097567
    [Abstract] [Full Text] [Related]

  • 19. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S, Horton R, Antonipillai I, Manoogian C, Ehrlich L, Nadler J.
    J Clin Endocrinol Metab; 1989 Dec 01; 69(6):1116-21. PubMed ID: 2573613
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ, Smith JM, Shebuski RJ, Ruffolo RR.
    J Pharmacol Exp Ther; 1987 Aug 01; 242(2):573-8. PubMed ID: 2886644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.